+1 (704) 266-3234

China Anticoagulants Market Report & Forecast 2021-2027

Published on: Aug 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 92

China Anticoagulants Market, By Type, 2016-2021, 2022-2027 ($ Millions)
China Anticoagulants Market Segment Percentages, By Type, 2020 (%)
Platelet Aggregation Inhibitors (PAI)
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Direct Factor Xa Inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others

China Anticoagulants Market, By Application, 2016-2021, 2022-2027 ($ Millions)
China Anticoagulants Market Segment Percentages, By Application, 2020 (%)
VTE
ACS/MI
AF
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticoagulants revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Anticoagulants revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson.
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company

1 Introduction to Research & Analysis Reports
1.1 Anticoagulants Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Anticoagulants Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Anticoagulants Overall Market Size
2.1 China Anticoagulants Market Size: 2021 VS 2027
2.2 China Anticoagulants Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints

3 Company Landscape
3.1 Top Anticoagulants Players in China Market
3.2 Top China Anticoagulants Companies Ranked by Revenue
3.3 China Anticoagulants Revenue by Companies
3.4 Top 3 and Top 5 Anticoagulants Companies in China Market, by Revenue in 2020
3.5 Companies Anticoagulants Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anticoagulants Players in China Market
3.6.1 List of Tier 1 Anticoagulants Companies in China
3.6.2 List of Tier 2 and Tier 3 Anticoagulants Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Anticoagulants Market Size Markets, 2021 & 2027
4.1.2 Platelet Aggregation Inhibitors (PAI)
4.1.3 Low-Molecular-Weight Heparin (LMWH)
4.1.4 Direct Thrombin Inhibitor (DTI)
4.1.5 Direct Factor Xa Inhibitors (DFXa)
4.1.6 Vitamin K antagonists (VKA)
4.1.7 Others
4.2 By Type - China Anticoagulants Revenue & Forecasts
4.2.1 By Type - China Anticoagulants Revenue, 2016-2021
4.2.2 By Type - China Anticoagulants Revenue, 2022-2027
4.2.3 By Type - China Anticoagulants Revenue Market Share, 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Anticoagulants Market Size, 2021 & 2027
5.1.2 VTE
5.1.3 ACS/MI
5.1.4 AF
5.1.5 Others
5.2 By Application - China Anticoagulants Revenue & Forecasts
5.2.1 By Application - China Anticoagulants Revenue, 2016-2021
5.2.2 By Application - China Anticoagulants Revenue, 2022-2027
5.2.3 By Application - China Anticoagulants Revenue Market Share, 2016-2027

6 Anticoagulants Companies Profiles
6.1 Sanofi
6.1.1 Sanofi Company Details
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Anticoagulants Introduction
6.1.4 Sanofi Anticoagulants Revenue in China Market (2016-2021)
6.1.5 Sanofi Recent Developments
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Company Details
6.2.2 Bristol-Myers Squibb Business Overview
6.2.3 Bristol-Myers Squibb Anticoagulants Introduction
6.2.4 Bristol-Myers Squibb Anticoagulants Revenue in China Market (2016-2021)
6.2.5 Bristol-Myers Squibb Recent Developments
6.3 Bayer
6.3.1 Bayer Company Details
6.3.2 Bayer Business Overview
6.3.3 Bayer Anticoagulants Introduction
6.3.4 Bayer Anticoagulants Revenue in China Market (2016-2021)
6.3.5 Bayer Recent Developments
6.4 Johnson & Johnson.
6.4.1 Johnson & Johnson. Company Details
6.4.2 Johnson & Johnson. Business Overview
6.4.3 Johnson & Johnson. Anticoagulants Introduction
6.4.4 Johnson & Johnson. Anticoagulants Revenue in China Market (2016-2021)
6.4.5 Johnson & Johnson. Recent Developments
6.5 Genentech (Roche)
6.5.1 Genentech (Roche) Company Details
6.5.2 Genentech (Roche) Business Overview
6.5.3 Genentech (Roche) Anticoagulants Introduction
6.5.4 Genentech (Roche) Anticoagulants Revenue in China Market (2016-2021)
6.5.5 Genentech (Roche) Recent Developments
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Company Details
6.6.2 Boehringer Ingelheim Business Overview
6.6.3 Boehringer Ingelheim Anticoagulants Introduction
6.6.4 Boehringer Ingelheim Anticoagulants Revenue in China Market (2016-2021)
6.6.5 Boehringer Ingelheim Recent Developments
6.7 Lilly
6.7.1 Lilly Company Details
6.7.2 Lilly Business Overview
6.7.3 Lilly Anticoagulants Introduction
6.7.4 Lilly Anticoagulants Revenue in China Market (2016-2021)
6.7.5 Lilly Recent Developments
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Company Details
6.8.2 Daiichi Sankyo Business Overview
6.8.3 Daiichi Sankyo Anticoagulants Introduction
6.8.4 Daiichi Sankyo Anticoagulants Revenue in China Market (2016-2021)
6.8.5 Daiichi Sankyo Recent Developments
6.9 Otsuka
6.9.1 Otsuka Company Details
6.9.2 Otsuka Business Overview
6.9.3 Otsuka Anticoagulants Introduction
6.9.4 Otsuka Anticoagulants Revenue in China Market (2016-2021)
6.9.5 Otsuka Recent Developments
6.10 AstraZeneca
6.10.1 AstraZeneca Company Details
6.10.2 AstraZeneca Business Overview
6.10.3 AstraZeneca Anticoagulants Introduction
6.10.4 AstraZeneca Anticoagulants Revenue in China Market (2016-2021)
6.10.5 AstraZeneca Recent Developments
6.11 Pfizer
6.11.1 Pfizer Company Details
6.11.2 Pfizer Business Overview
6.11.3 Pfizer Anticoagulants Introduction
6.11.4 Pfizer Anticoagulants Revenue in China Market (2016-2021)
6.11.5 Pfizer Recent Developments
6.12 Aspen
6.12.1 Aspen Company Details
6.12.2 Aspen Business Overview
6.12.3 Aspen Anticoagulants Introduction
6.12.4 Aspen Anticoagulants Revenue in China Market (2016-2021)
6.12.5 Aspen Recent Developments
6.13 The Medicines Company
6.13.1 The Medicines Company Company Details
6.13.2 The Medicines Company Business Overview
6.13.3 The Medicines Company Anticoagulants Introduction
6.13.4 The Medicines Company Anticoagulants Revenue in China Market (2016-2021)
6.13.5 The Medicines Company Recent Developments

7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer

List of Tables
Table 1. Anticoagulants Market Opportunities & Trends in China Market
Table 2. Anticoagulants Market Drivers in China Market
Table 3. Anticoagulants Market Restraints in China Market
Table 4. Key Players of Anticoagulants in China Market
Table 5. Top Anticoagulants Players in China Market, Ranking by Revenue (2019)
Table 6. China Anticoagulants Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Anticoagulants Revenue Share by Companies, 2016-2021
Table 8. Companies Anticoagulants Product Type
Table 9. List of Tier 1 Anticoagulants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Anticoagulants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type Ð China Anticoagulants Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Anticoagulants Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Anticoagulants Revenue (US$, Mn), 2022-2027
Table 14. By Application Ð China Anticoagulants Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Anticoagulants Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Anticoagulants Revenue (US$, Mn), 2022-2027
Table 17. Sanofi Company Details
Table 18. Sanofi Business Overview
Table 19. Sanofi Anticoagulants Product
Table 20. Sanofi Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Sanofi Recent Developments
Table 22. Bristol-Myers Squibb Company Details
Table 23. Bristol-Myers Squibb Business Overview
Table 24. Bristol-Myers Squibb Anticoagulants Product
Table 25. Bristol-Myers Squibb Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Bristol-Myers Squibb Recent Developments
Table 27. Bayer Company Details
Table 28. Bayer Business Overview
Table 29. Bayer Anticoagulants Product
Table 30. Bayer Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Bayer Recent Developments
Table 32. Johnson & Johnson. Company Details
Table 33. Johnson & Johnson. Business Overview
Table 34. Johnson & Johnson. Anticoagulants Product
Table 35. Johnson & Johnson. Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Johnson & Johnson. Recent Developments
Table 37. Genentech (Roche) Company Details
Table 38. Genentech (Roche) Business Overview
Table 39. Genentech (Roche) Anticoagulants Product
Table 40. Genentech (Roche) Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Genentech (Roche) Recent Developments
Table 42. Boehringer Ingelheim Company Details
Table 43. Boehringer Ingelheim Business Overview
Table 44. Boehringer Ingelheim Anticoagulants Product
Table 45. Boehringer Ingelheim Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Boehringer Ingelheim Recent Developments
Table 47. Lilly Company Details
Table 48. Lilly Business Overview
Table 49. Lilly Anticoagulants Product
Table 50. Lilly Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Lilly Recent Developments
Table 52. Daiichi Sankyo Company Details
Table 53. Daiichi Sankyo Business Overview
Table 54. Daiichi Sankyo Anticoagulants Product
Table 55. Daiichi Sankyo Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Daiichi Sankyo Recent Developments
Table 57. Otsuka Company Details
Table 58. Otsuka Business Overview
Table 59. Otsuka Anticoagulants Product
Table 60. Otsuka Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Otsuka Recent Developments
Table 62. AstraZeneca Company Details
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca Anticoagulants Product
Table 65. AstraZeneca Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 66. AstraZeneca Recent Developments
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Anticoagulants Product
Table 70. Pfizer Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Developments
Table 72. Aspen Company Details
Table 73. Aspen Business Overview
Table 74. Aspen Anticoagulants Product
Table 75. Aspen Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 76. Aspen Recent Developments
Table 77. The Medicines Company Company Details
Table 78. The Medicines Company Business Overview
Table 79. The Medicines Company Anticoagulants Product
Table 80. The Medicines Company Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 81. The Medicines Company Recent Developments
List of Figures
Figure 1. Anticoagulants Segment by Type
Figure 2. Anticoagulants Segment by Application
Figure 3. China Anticoagulants Market Overview: 2020
Figure 4. China Anticoagulants Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Anticoagulants Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Anticoagulants Revenue in 2020
Figure 7. By Type - China Anticoagulants Revenue Market Share, 2016-2027
Figure 8. By Application - China Anticoagulants Revenue Market Share, 2016-2027
Figure 9. Sanofi Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Bristol-Myers Squibb Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Bayer Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Johnson & Johnson. Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Genentech (Roche) Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Boehringer Ingelheim Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Lilly Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Daiichi Sankyo Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Otsuka Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. AstraZeneca Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Pfizer Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Aspen Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. The Medicines Company Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.